137 related articles for article (PubMed ID: 21073537)
1. Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
Oliveira LR; Oliveira-Costa JP; Araujo IM; Soave DF; Zanetti JS; Soares FA; Zucoloto S; Ribeiro-Silva A
J Oral Pathol Med; 2011 Feb; 40(2):135-42. PubMed ID: 21073537
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma.
Todoroki K; Ogasawara S; Akiba J; Nakayama M; Naito Y; Seki N; Kusukawa J; Yano H
Int J Oncol; 2016 Jan; 48(1):99-109. PubMed ID: 26647656
[TBL] [Abstract][Full Text] [Related]
5. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.
Grimm M; Krimmel M; Polligkeit J; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Reinert S; Hoefert S
Eur J Cancer; 2012 Nov; 48(17):3186-97. PubMed ID: 22784549
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase expression in oral squamous cell carcinoma: relationship with cancer stem cells profiles and lymph node metastasis.
Oliveira-Costa JP; Oliveira LR; da Silveira GG; Soave DF; Soares FA; Ribeiro-Silva A
J Oral Pathol Med; 2012 Nov; 41(10):762-8. PubMed ID: 22672768
[TBL] [Abstract][Full Text] [Related]
7. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
Abdulmajeed AA; Dalley AJ; Farah CS
J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines.
Felthaus O; Ettl T; Gosau M; Driemel O; Brockhoff G; Reck A; Zeitler K; Hautmann M; Reichert TE; Schmalz G; Morsczeck C
Biochem Biophys Res Commun; 2011 Apr; 407(1):28-33. PubMed ID: 21342656
[TBL] [Abstract][Full Text] [Related]
9. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
10. Catenin expression in T1/2 carcinomas of the floor of the mouth.
Fillies T; Buerger H; Gaertner C; August C; Brandt B; Joos U; Werkmeister R
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):907-11. PubMed ID: 15916880
[TBL] [Abstract][Full Text] [Related]
11. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
[TBL] [Abstract][Full Text] [Related]
13. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.
Fillies T; Woltering M; Brandt B; Van Diest JP; Werkmeister R; Joos U; Buerger H
Oncol Rep; 2007 Feb; 17(2):355-9. PubMed ID: 17203174
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas.
Tosco P; La Terra Maggiore GM; Forni P; Berrone S; Chiusa L; Garzino-Demo P
Oral Dis; 2011 Jan; 17(1):102-8. PubMed ID: 20659261
[TBL] [Abstract][Full Text] [Related]
17. Is the new TNM (1997) the best system for predicting prognosis?
Carinci F; Farina A; Longhini L; Urso RG; Pelucchi S; Calearo C
Int J Oral Maxillofac Surg; 1999 Jun; 28(3):203-5. PubMed ID: 10355943
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
Kademani D; Bell RB; Bagheri S; Holmgren E; Dierks E; Potter B; Homer L
J Oral Maxillofac Surg; 2005 Nov; 63(11):1599-605. PubMed ID: 16243176
[TBL] [Abstract][Full Text] [Related]
20. Salvage treatment for recurrent oral squamous cell carcinoma.
Sun GW; Tang EY; Yang XD; Hu QG
J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]